Publications by authors named "Jacob Abarca"

Claim this Profile
E
Effectiveness, safety and treatment adherence of biosimilar follow-on insulin in diabetes management.
Timothy T Pham, Xiaoxue Chen, John Barron, Richard Hart, Jacob Abarca

Diabetes Obes Metab· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation.
Gboyega Adeboyeje, Gosia Sylwestrzak, John J Barron, Jeff White, Alan Rosenberg, Jacob Abarca

J Manag Care Spec Pharm· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost.
Karen E Martin, Jingbo Yu, H Eloise Campbell, Jacob Abarca, T Jeffrey White

J Manag Care Pharm· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.
Yu Ko, Daniel C Malone, Grant H Skrepnek, Edward P Armstrong, John E Murphy, Jacob Abarca

Drug Saf· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender and age differences in medications dispensed from a national chain drugstore.
Marietta Anthony, Kwan Y Lee, Carl T Bertram, Jacob Abarca, Rick A Rehfeld

J Womens Health (Larchmt)· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of delayed initiation of erythropoietin in critically ill patients.
Jeremiah J Duby, Brian L Erstad, Jacob Abarca, James M Camamo, Yvonne Huckleberry

BMC Blood Disord· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index.
Rita A Snyder, Jacob Abarca, Jane L Meza, Jeffrey M Rothschild, Albert Rizos

Pharmacoepidemiol Drug Saf· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential drug-drug interactions within Veterans Affairs medical centers.
Maysaa Mahmood, Daniel C Malone, Grant H Skrepnek, Jacob Abarca, Edward P Armstrong

Am J Health Syst Pharm· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
Daniel C Malone, Jacob Abarca, Grant H Skrepnek, John E Murphy, Edward P Armstrong

Med Care· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practitioners' views on computerized drug-drug interaction alerts in the VA system.
Yu Ko, Jacob Abarca, Daniel C Malone, Donna C Dare, Doug Geraets

J Am Med Inform Assoc· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic management of constipation in the critically ill patient.
Asad E Patanwala, Jacob Abarca, Yvonne Huckleberry, Brian L Erstad

Pharmacotherapy· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies.
Jacob Abarca, Lisa R Colon, Victoria S Wang, Daniel C Malone, John E Murphy

J Manag Care Pharm· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community pharmacy managers' perception of computerized drug-drug interaction alerts.
Jacob Abarca, Daniel C Malone, Grant H Skrepnek, Rick A Rehfeld, John E Murphy

J Am Pharm Assoc (2003)· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Workload and availability of technology in metropolitan community pharmacies.
Grant H Skrepnek, Edward P Armstrong, Daniel C Malone, Jacob Abarca, John E Murphy

J Am Pharm Assoc (2003)· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
Grant H Skrepnek, Jacob Abarca, Daniel C Malone, Edward P Armstrong, Farshad M Shirazi

Ann Pharmacother· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of the use of etanercept versus infliximab determined from medical chart audit.
Jacob Abarca, Daniel C Malone, Edward P Armstrong, Amy J Grizzle, Marc D Cohen

J Manag Care Pharm· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using community indicators to assess nutrition in Arizona-Mexico border communities.
Jacob Abarca, Sulabha Ramachandran

Prev Chronic Dis· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance of severity ratings provided in four drug interaction compendia.
Jacob Abarca, Daniel C Malone, Edward P Armstrong, Amy J Grizzle, Philip D Hansten

J Am Pharm Assoc (2003)· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
Daniel C Malone, Jacob Abarca, Philip D Hansten, Amy J Grizzle, Edward P Armstrong

J Am Pharm Assoc (2003)· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalization.
Jacob Abarca, Daniel C Malone, Edward P Armstrong, Woodie M Zachry

Pharmacotherapy· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis